Somewhat Positive Media Coverage Somewhat Unlikely to Impact Lannett (LCI) Share Price

Media stories about Lannett (NYSE:LCI) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Lannett earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.5209882863461 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

These are some of the news articles that may have impacted Accern’s analysis:

How to Become a New Pot Stock Millionaire

Several equities analysts recently issued reports on LCI shares. Roth Capital set a $25.00 target price on Lannett and gave the company a “buy” rating in a research report on Wednesday, February 7th. Oppenheimer reissued a “hold” rating on shares of Lannett in a research report on Wednesday, February 7th. ValuEngine downgraded Lannett from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Zacks Investment Research downgraded Lannett from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 13th. Finally, BMO Capital Markets cut their target price on Lannett from $22.00 to $21.00 and set a “market perform” rating on the stock in a research report on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $20.83.

NYSE:LCI traded down $0.10 during mid-day trading on Tuesday, hitting $16.80. The company’s stock had a trading volume of 75,504 shares, compared to its average volume of 697,028. Lannett has a 1 year low of $14.40 and a 1 year high of $30.35. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.77 and a current ratio of 2.32. The firm has a market cap of $622.53, a price-to-earnings ratio of 5.87, a PEG ratio of 1.05 and a beta of 2.50.

Lannett (NYSE:LCI) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.86 by $0.20. Lannett had a net margin of 7.44% and a return on equity of 18.85%. The company had revenue of $184.31 million for the quarter, compared to analyst estimates of $190.92 million. During the same period in the prior year, the company earned $0.92 earnings per share. The firm’s revenue was up 7.8% on a year-over-year basis. equities research analysts predict that Lannett will post 3.13 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Lannett (LCI) Share Price” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at

About Lannett

Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages.

Insider Buying and Selling by Quarter for Lannett (NYSE:LCI)

Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with's FREE daily email newsletter.

Leave a Reply